Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France

Saved in:
Bibliographic Details
Main Authors: S. Dalle, P. Saiag, C. Lebbé, J.-J. Grob, B. Dréno, S. Dalac, B. Asselain, F. Skowron, S. Darras, N. Jovenin, G. Quereux, A. Khammari, C. Rieuf, F. Brellier, S. Houssou, L. Mortier
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:EJC Skin Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2772611824001575
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850162945970929664
author S. Dalle
P. Saiag
C. Lebbé
J.-J. Grob
B. Dréno
S. Dalac
B. Asselain
F. Skowron
S. Darras
N. Jovenin
G. Quereux
A. Khammari
C. Rieuf
F. Brellier
S. Houssou
L. Mortier
author_facet S. Dalle
P. Saiag
C. Lebbé
J.-J. Grob
B. Dréno
S. Dalac
B. Asselain
F. Skowron
S. Darras
N. Jovenin
G. Quereux
A. Khammari
C. Rieuf
F. Brellier
S. Houssou
L. Mortier
author_sort S. Dalle
collection DOAJ
format Article
id doaj-art-d1143e8208674518b18540ac41ecb5e1
institution OA Journals
issn 2772-6118
language English
publishDate 2024-01-01
publisher Elsevier
record_format Article
series EJC Skin Cancer
spelling doaj-art-d1143e8208674518b18540ac41ecb5e12025-08-20T02:22:25ZengElsevierEJC Skin Cancer2772-61182024-01-01210016910.1016/j.ejcskn.2024.100169Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in FranceS. Dalle0P. Saiag1C. Lebbé2J.-J. Grob3B. Dréno4S. Dalac5B. Asselain6F. Skowron7S. Darras8N. Jovenin9G. Quereux10A. Khammari11C. Rieuf12F. Brellier13S. Houssou14L. Mortier15Lyon Sud Hospital, Department of Dermatology, Lyon, FranceAmbroise Paré Hospital, Department of Dermatology, Boulogne Billancourt, FranceSaint Louis Hospital, Paris Cite University, APHP Dermato oncology and CIC, Cancer Institute APHP Nord Paris Cité INSERM U976, Paris, FranceAPHM Timone Hospital, Department of Dermatology, Marseille, FranceNantes University, Nantes University Hospital, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, FranceDijon Bourgogne University Hospital, Department of Dermatology, Dijon, FranceGINECO group Paris France, Department of Biostatistics, Paris, FranceDrôme Nord Hospital, Department of Dermatology, Romans sur Isère, FranceBoulogne sur Mer Hospital, Department of Dermatology, Boulogne sur Mer, FranceCourlancy Polyclinic, Department of Oncology, Reims, FranceNantes University, Nantes University Hospital, Department of Dermatology, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, FranceNantes University, Nantes University Hospital, Department of Dermatology, CIC 1413, Inserm UMR 1302/EMR6001 INCIT, Nantes, FranceBristol Myers Squibb, Rueil Malmaison, FranceBristol Myers Squibb, Rueil Malmaison, FranceBristol Myers Squibb, Rueil Malmaison, FranceLille University Hospital, Department of Dermatology, Lille, Francehttp://www.sciencedirect.com/science/article/pii/S2772611824001575
spellingShingle S. Dalle
P. Saiag
C. Lebbé
J.-J. Grob
B. Dréno
S. Dalac
B. Asselain
F. Skowron
S. Darras
N. Jovenin
G. Quereux
A. Khammari
C. Rieuf
F. Brellier
S. Houssou
L. Mortier
Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
EJC Skin Cancer
title Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
title_full Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
title_fullStr Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
title_full_unstemmed Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
title_short Updated outcomes of AdjuMel study: real-world data in patients with resected stage III-IV melanoma treated with adjuvant nivolumab in France
title_sort updated outcomes of adjumel study real world data in patients with resected stage iii iv melanoma treated with adjuvant nivolumab in france
url http://www.sciencedirect.com/science/article/pii/S2772611824001575
work_keys_str_mv AT sdalle updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT psaiag updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT clebbe updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT jjgrob updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT bdreno updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT sdalac updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT basselain updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT fskowron updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT sdarras updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT njovenin updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT gquereux updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT akhammari updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT crieuf updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT fbrellier updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT shoussou updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance
AT lmortier updatedoutcomesofadjumelstudyrealworlddatainpatientswithresectedstageiiiivmelanomatreatedwithadjuvantnivolumabinfrance